Haemonetics
Haemonetics Corp is a global medical technology enterprise headquartered in Boston, Massachusetts. The company designs, manufactures, and markets blood management solutions, medical devices, and consumables for healthcare providers. Its product portfolio features automated blood collection systems, plasma extraction devices, hospital blood bank technologies, and vascular closure tools. Principal revenue is derived from selling proprietary medical devices, single-use disposable sets, and software support services to hospitals, blood centers, and plasma collectors. The enterprise serves global healthcare clinical environments. Haemonetics Corp is publicly traded on the New York Stock Exchange.
8 of the funds FundTelligence covers report a position in Haemonetics.
- Legal name
- Haemonetics Corp
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 8
Funds holding Haemonetics
- T. Rowe Price US Smaller Companies Equity Fund — T. Rowe Price · 0.85 % (full portfolio disclosed, September 2026)
- Mercer Global Small Cap Equity Fund — Mercer · 0.46 % (full portfolio disclosed, December 2025)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.4 % (full portfolio disclosed, September 2026)
- Schroder ISF Global Convertible Bond — Schroders · 0.2 % (full portfolio disclosed, June 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.07 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.05 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.04 % (partially disclosed portfolio, June 2026)
- Nordea Internationale aktier — Nordea Funds · 0.02 % (full portfolio disclosed, September 2026)